Trimethoprim(for veterinary)
CAS number: 738-70-5
Molecular formula: C14H18N4O3
molecular weight: 290.32
Chemical structure:
Producers shown on SFDA
(Record date:26/10/2021)
Producer | Documents | GMP Valid till(based on SFDA) |
Shouguang Fukang Animal Pharmaceutical Co., Ltd. | GMP | Valid till April 2024 |
Shandong Xinhua Pharmaceutical Co., Ltd. | GMP | Valid till January 2024 |
Foshan Nanhai Beisha Pharmaceutical Co., Ltd. | GMP | Valid till January 2022 |
Producers shown on EP
(Quoted from EP website;record date:26/10/2021)
Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
Trimethoprim | Welding GmbH & Co KG Hamburg DE | R0-CEP 1999-132 - Rev 02 | 14/12/2004 | Withdrawn by Holder | 31/07/2005 | Chemical |
Trimethoprim | Dong Wha Pharm Ind Co Ltd Seoul KR | R1-CEP 1998-149 - Rev 01 | 11/05/2010 | Valid | / | Chemical |
Trimethoprim | TEVA PHARMACEUTICAL INDUSTRIES LTD. Petach Tikva IL | R1-CEP 2007-073 - Rev 00 | 25/09/2014 | Valid | / | Chemical |
Trimethoprim | SHOUGUANG FUKANG PHARMACEUTICAL CO., LTD. Shouguang City CN | R1-CEP 2005-115 - Rev 01 | 25/06/2015 | Valid | / | Chemical |
Trimethoprim | SHANDONG XINHUA PHARMACEUTICAL CO., LTD. Zibo CN | R1-CEP 2003-195 - Rev 04 | 24/08/2015 | Valid | / | Chemical |
Trimethoprim | Punjab Chemicals and Crop Protection Limited Lalru IN | R1-CEP 1999-037 - Rev 03 | 16/10/2015 | Withdrawn by Holder | 03/12/2018 | Chemical |
Trimethoprim | SOUTHWEST SYNTHETIC PHARMACEUTICAL CORPORATION, LIMITED Chongqing CN | R1-CEP 1997-009 - Rev 05 | 08/12/2015 | Withdrawn by EDQM Failure to CEP procedure | 21/05/2021 | Chemical |
Trimethoprim | IPCA Laboratories Limited Mumbai IN | R1-CEP 1999-104 - Rev 06 | 21/02/2017 | Valid | / | Chemical |
Trimethoprim | INVENTAA INDUSTRIES PRIVATE LIMITED Hyderabad IN | R1-CEP 1999-194 - Rev 02 | 02/10/2017 | Valid | / | Chemical |
Trimethoprim | SHANDONG RONGYUAN PHARMACEUTICAL CO., LTD. Yangkou Town CN | R1-CEP 2011-345 - Rev 00 | 14/05/2018 | Valid | / | Chemical |
Producer:Shouguang Fukang Animal Pharmaceutical Co., Ltd., established in 2005, is subordinate to Shouguang Fukang Pharmaceutical Co., Ltd.
Shandong Fukang group produces chemical raw materials trimethoprim (TMP), omeprazole, sulfamethoxazole (SMZ), metformin hydrochloride and chloronitrogen, and the average production and sales volume ranks among the top in China. The company has passed China GMP certification, the United States, the European Union, the World Health Organization, France, Australia, Japan, South Korea, Mexico and other international authoritative quality certification.
Staff size:About 50 people
Registered capital:RMB 3 million
Producer:Shandong Xinhua Pharmaceutical Co., Ltd., established in Jiaodong Anti Japanese base in 1943, is the first chemical synthetic pharmaceutical enterprise in China, an important global production and export base of antipyretic and analgesic drugs, and an important domestic manufacturer of cardio cerebrovascular, anti infection and central nervous system. It has three pillar industries of chemical raw materials, pharmaceutical preparations and pharmaceutical intermediates, five industrial parks and 13 subsidiaries. The annual production capacity of chemical APIs is 40000 tons, pharmaceutical intermediates is 500000 tons, solid preparations are 28 billion tablets (tablets), and injections are 1 billion.
At present, all the drugs in production of Xinhua Pharmaceutical have passed the new national GMP certification, 18 products have passed the FDA inspection, 10 products have obtained the EU cos certificate, and the tablets have passed the MHRA audit of the UK drug and health products administration. More than 3 billion tablets have been exported to the EU high-end market, It has become one of the first 15 leading enterprises implementing the internationalization strategy of preparations in China and one of the top ten enterprises in the export of preparations in China.
Staff size:About 7000 people
Registered capital:RMB 627 million 400 thousand
Producer:Foshan Nanhai Beisha Pharmaceutical Co., Ltd. has passed GMP certification. Produce a variety of pharmaceutical raw materials, mainly anti infection and anti-inflammatory raw materials - sulfonamides and macrolides, such as sulfamethazine and its sodium salt, sulfadiazine and its sodium salt, sulfamethoxazole and trimethoprim; Roxithromycin et al. The products have been exported to Europe, America, Japan, Southeast Asia and other international markets, with an annual output of more than 3000 tons.
Staff size:200-299 people
Registered capital:RMB 48 million
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978